Novelion therapeutics inc. (NVLN)
Income statement / Quarterly
Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Net revenues

32,200

-

-

-

27,484

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenues

-

-

30,334

31,904

-

-

28,669

40,877

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product sales

15,219

17,958

12,531

15,703

13,505

-

29,505

14,277

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenues

-

-

-

-

-

-

-

-

29,984

13,574

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,908

5,590

5,535

8,780

Royalties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,777

3,310

3,050

3,596

Revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,685

8,900

8,585

12,376

Cost of product sales

-

-

-

-

-

-

-

-

16,445

5,971

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,411

1,338

1,869

3,392

Operating expenses:
Selling, general and administrative

26,035

14,059

18,348

23,735

23,689

24,112

21,395

26,514

24,451

15,953

3,162

4,474

5,936

2,283

3,166

7,154

3,619

9,040

2,388

4,098

2,156

1,418

1,676

1,810

2,082

2,433

2,669

5,872

4,108

11

3,693

6,259

7,096

5,354

5,034

Research and development

6,934

7,663

9,031

10,360

11,766

11,772

17,112

10,824

9,300

6,010

2,855

2,929

2,990

2,036

2,142

3,404

2,208

2,119

2,792

4,079

4,813

4,794

5,243

4,392

4,080

4,957

5,639

7,465

6,517

-4,123

6,113

11,319

9,734

8,101

7,329

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

229

-

230

252

235

238

238

326

363

286

294

370

342

306

303

Restructuring charges

-

-

2,151

0

-

-5

56

1,034

1,451

0

0

0

0

-

-

-

-

1

0

172

571

184

354

671

822

-

11,402

-

-

-

0

-

-

-

-

Total operating expenses

32,969

21,722

29,530

34,095

35,455

35,879

38,563

38,372

35,202

21,963

6,017

7,403

8,926

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

141

179

188

-

222

229

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Termination fee (Note 3)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,667

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Termination fee (Note 3)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,782

10,737

6,015

-

5,402

8,578

7,769

6,643

7,503

7,125

7,219

10,076

19,948

13,663

10,988

-8,575

10,100

21,359

18,510

15,630

16,058

Loss from operations

-15,988

1,030

-11,727

-17,894

-21,476

-13,964

-39,399

-11,772

-21,663

-14,360

-6,017

-7,403

-8,926

-3,811

-2,782

-10,737

-6,015

17,920

-5,402

-8,578

-7,769

-6,643

-7,503

-7,125

-7,219

-10,076

-19,948

-13,663

-10,988

-13,010

-10,100

-8,674

-9,610

-7,045

-3,682

Interest expense, net

-15,510

-15,996

-12,022

-11,594

-10,886

-10,315

-9,897

-9,613

-9,212

-3,199

110

54

75

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value loss on investment

-

-

-

-

-

-

-

-

-

-36

0

2,256

-12,960

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net foreign exchange loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-43

-60

98

-

0

-53

-21

4

-54

84

-66

76

65

-32

-117

-187

-298

58

279

409

-972

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

152

51

32

-

27

31

22

35

39

80

57

-

59

56

-

-

-

-

-

-

-

Fair value loss on investment (Notes 2(b))

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33

-

146

178

210

602

515

Fair value change in contingent consideration (Notes 7, 14)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,466

961

71

1,038

795

1,783

2,840

1,650

1,942

-

-

-

-

-

-

Other expense, net

-560

131

-926

-728

-307

-468

49

75

52

-1,756

-144

-22

-77

89

-6

0

-2

-595

17

42

55

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,966

-5,358

-8,558

-6,247

-5,536

-7,383

-5,887

-6,433

-8,163

-16,963

-11,960

-9,078

-9,248

-8,415

-5,676

-6,839

-804

-1,254

Fair value change in contingent consideration (Notes 7 and 10)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,828

2,753

2,282

5,206

2,519

Other gains

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64

36

-

-42

21

29

52

595

9

9

0

24

366

Total other (expense) income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

103

-9

128

-

44

20

1,522

1,107

120

1,238

786

1,913

2,985

1,703

1,910

3,762

1,685

2,998

2,771

6,241

2,428

Loss before provision for income taxes

-32,058

-19,168

-24,675

-30,216

-32,669

-24,747

-49,247

-21,310

-30,823

-19,351

-6,051

-5,115

-21,888

-3,675

-2,679

-10,746

-5,887

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Benefit from (Provision for) income taxes

-200

220

133

1,046

200

-179

497

126

139

569

-115

5

6

5

3

5

9

2

-432

23

215

165

109

142

183

-103

-4,345

251

297

-1,239

261

469

1,710

-107

-239

Net Income (Loss) Attributable to Parent

-31,800

-19,402

-24,808

-31,262

-32,828

-24,568

-49,744

-21,436

-30,962

-19,920

-5,936

-5,120

-21,894

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,277

-

-9,106

-6,145

-8,549

-697

-1,015

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,926

-8,581

-

-5,701

-7,492

-6,029

-6,616

-8,060

-12,618

-12,211

-9,375

-

-8,676

-

-

-

-

(Loss) income from discontinued operations, net of income taxes (Note 12)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

-57

-

852

96

-170

189

-

94,078

-

-

-

-

-

-

-

-

Net loss and comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,682

-10,751

-5,896

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) Income from discontinued operations, net of income taxes (Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,093

902

-

430

-

-

-

-

Net loss and comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,932

-8,638

-6,462

-

-7,396

-6,199

-6,427

-

81,460

-16,304

-

-

-

-

-

-

-

Continuing operations (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.10

-0.17

-

-0.11

-0.15

-0.12

-0.13

-0.15

-0.25

-0.25

-0.19

-

-0.17

-

-

-

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

-

0.02

0.00

0.00

0.00

-0.01

1.86

-0.08

-0.02

-

-0.01

-

-

-

-

Net loss per common share—basic and diluted (in usd per share)

-1.67

-1.01

-1.32

-1.67

-1.76

-1.32

-2.67

-1.15

-1.67

-1.58

-0.56

-0.48

-2.07

-1.82

-0.05

-0.21

-0.12

0.00

-0.10

-0.17

-0.13

-0.10

-0.14

-0.12

-0.13

-0.16

1.61

-0.33

-0.21

-0.14

-0.18

-0.12

-0.17

-0.01

-0.02

Weighted-average shares outstanding—basic and diluted (in shares)

19,022

18,932

18,854

18,759

18,703

18,667

18,648

18,609

18,540

13,441

10,565

10,565

10,565

-114,109

52,829

51,779

51,237

-61,384

51,151

51,082

51

51,082

51,082

50,883

50,589

102,222

50

49,191

48,984

-

-

-

-

-

-

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

50

51,023

51,656

53,009

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

50

51,023

51,656

53,009